Cutler Group LP Anavex Life Sciences Corp. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	BUY	$7.65 - $14.43 $40,545 - $76,479	5,300 New	5,300 $3,000
Q2 2022 Aug 04, 2022	SELL	$7.31 - $12.84 $22,661 - $39,804	-3,100 Reduced 86.11%	500 $1,000
Q1 2022 Apr 14, 2022	SELL	$9.74 - $17.69 $128,568 - $233,508	-13,200 Reduced 78.57%	3,600 $2,000
Q4 2017 Jan 17, 2018	SELL	$3.12 - $4.94 $85,800 - $135,850	-27,500 Reduced 62.08%	16,800 $7,000
Q3 2017 Oct 17, 2017	BUY	$3.42 - $4.87 $151,506 - $215,741	44,300	44,300 $41,000

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.